EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach

Jashanpreet Kaur iD, Gursimran Kaur iD, Chamanpreet Kaur, Sandeep Kumar iD

Journal of Food and Drug Analysis · 17.09.2025 · 33 (3) · 213-223

DOI: 10.38212/2224-6614.3550 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 17.09.2025. Verfasst von Jashanpreet Kaur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, 140111, India. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary Hypertension (PH) is a progressive and potentially fatal condition marked by high pulmonary arterypressure, resulting in heart failure and reduced oxygenation. Despite advancements in treatments, therapeutic optionsfor PH remain limited, particularly in cases resistant to conventional therapies. In biomedical research, nanotechnologyhas become a potential area of study, presenting novel approaches to drug delivery and tissue targeting. Nanosponges, aclass of nanoparticles with porous structures, have gained attention for their ability to encapsulate therapeutic agents,enhance drug stability, and provide controlled release. Nanosponges can be engineered to deliver vasodilators, anti-inflammatory drugs, and gene therapies directly to the pulmonary vasculature, minimizing systemic side effects andimproving drug efficacy. Additionally, their unique surface properties allow for targeted delivery to specific cells or tissues involved in PH, such as the pulmonary arteries' smooth muscle and endothelial cells. This review explores the potential role of nanosponges in pulmonary hypertension, highlighting recent advances in their design and function-alization. The integration of nanosponges into PH therapy could revolutionize the treatment landscape, offering more effective and individualized treatment plans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryNanoparticlesDrug Delivery SystemsHumansAnimals

Autor:innen und Institutionen

  • Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, 140111, India.

ORCID-Profile: Jashanpreet Kaur, Gursimran Kaur, Sandeep Kumar

Zitieren

APA

Kaur, J., Kaur, G., Kaur, C., & Kumar, S. (2025). Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach. Journal of Food and Drug Analysis, 33(3), 213-223. https://doi.org/10.38212/2224-6614.3550

Vancouver

Kaur J, Kaur G, Kaur C, Kumar S. Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach. Journal of Food and Drug Analysis. 2025;33(3):213-223. doi:10.38212/2224-6614.3550

BibTeX
@article{Kaur2025,
  author = {Kaur, Jashanpreet and Kaur, Gursimran and Kaur, Chamanpreet and Kumar, Sandeep},
  title = {Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach},
  journal = {Journal of Food and Drug Analysis},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {213--223},
  doi = {10.38212/2224-6614.3550}
}
Kostenlos starten →